Hotel Chocolat Group PLC Total Voting Rights (3686R)

TIDMHOTC

RNS Number : 3686R

Hotel Chocolat Group PLC

01 March 2023

1 March 2023

Hotel Chocolat Group plc

(" Hotel Chocolat ", the "Company" or the "Group")

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), Hotel Chocolat notifies the market of the following.

As at 28 February 2023, the Company's issued and fully paid share capital consisted of 137,537,554 ordinary shares of 0.1 pence each ("Ordinary Shares"), all of which carry one voting right per share. The Company does not hold any Ordinary Shares in Treasury.

The figure of 137,537,554 Ordinary Shares may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the DTRs.

For further information:

 
 Hotel Chocolat Group plc c/o Citigate + 44 (0) 20 7638 9571 
 Angus Thirlwell, Co-founder and Chief Executive Officer 
 Peter Harris, Co-founder and Development Director 
 
 Liberum Capital Limited - Nominated Adviser and Broker + 44 
  (0) 20 3100 2222 
 Clayton Bush 
 Edward Thomas 
 Miquela Bezuidenhoudt 
 
 Citigate Dewe Rogerson - Financial PR + 44 (0) 20 7638 9571 
 Angharad Couch 
 Ellen Wilton 
 Alex Winch 
 

Notes to Editors:

Hotel Chocolat is a premium British chocolate maker with a strong and distinctive D2C brand. The business was founded by Angus Thirlwell and Peter Harris, who are still executives within the business, and has traded under the Hotel Chocolat brand since 2003. The Group is unusual in being a grower (organic cacao farm in Saint Lucia), a manufacturer (Cambridgeshire) and owning its extensive direct to consumer channels (branded stores, websites). The Group was admitted to trading on AIM in 2016.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVREAAAPADFDEFA

(END) Dow Jones Newswires

March 01, 2023 02:00 ET (07:00 GMT)